These findings indicate that EGFR can be regulated by specific transcription factors, metabolites, kinases, and plant extracts to inhibit tumor cell proliferation, migration, and invasion by blocking downstream signals, thereby making it an important target for the precise treatment of breast cancer. This evidence concerns the gene EGFR and breast cancer.